ID ITAL_MOUSE Reviewed; 1162 AA. AC P24063; E9Q5M7; E9QNL8; Q3U159; DT 01-MAR-1992, integrated into UniProtKB/Swiss-Prot. DT 23-FEB-2022, sequence version 3. DT 27-MAR-2024, entry version 184. DE RecName: Full=Integrin alpha-L {ECO:0000305}; DE AltName: Full=CD11 antigen-like family member A; DE AltName: Full=Leukocyte adhesion glycoprotein LFA-1 alpha chain; DE Short=LFA-1A; DE AltName: Full=Leukocyte function-associated molecule 1 alpha chain; DE AltName: Full=Lymphocyte antigen 15; DE Short=Ly-15; DE AltName: CD_antigen=CD11a; DE Flags: Precursor; GN Name=Itgal {ECO:0000312|MGI:MGI:96606}; Synonyms=Lfa-1, Ly-15; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION. RX PubMed=2051027; RA Kaufmann Y., Tseng E., Springer T.A.; RT "Cloning of the murine lymphocyte function-associated molecule-1 alpha- RT subunit and its expression in COS cells."; RL J. Immunol. 147:369-374(1991). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=NOD; TISSUE=Spleen; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP PROTEIN SEQUENCE OF 24-42. RX PubMed=3887182; DOI=10.1038/314540a0; RA Springer T.A., Teplow D.B., Dreyer W.J.; RT "Sequence homology of the LFA-1 and Mac-1 leukocyte adhesion glycoproteins RT and unexpected relation to leukocyte interferon."; RL Nature 314:540-542(1985). RN [6] RP FUNCTION. RX PubMed=16234355; DOI=10.1182/blood-2005-08-3123; RA Liu Z., Zhao M., Li N., Diaz L.A., Mayadas T.N.; RT "Differential roles for beta2 integrins in experimental autoimmune bullous RT pemphigoid."; RL Blood 107:1063-1069(2006). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver, Lung, and Spleen; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [8] RP FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE. RX PubMed=24158516; DOI=10.1161/atvbaha.113.302077; RA Jiang E., Perrard X.D., Yang D., Khan I.M., Perrard J.L., Smith C.W., RA Ballantyne C.M., Wu H.; RT "Essential role of CD11a in CD8+ T-cell accumulation and activation in RT adipose tissue."; RL Arterioscler. Thromb. Vasc. Biol. 34:34-43(2014). RN [9] RP FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE. RX PubMed=25108025; DOI=10.4049/jimmunol.1301820; RA Bose T.O., Colpitts S.L., Pham Q.M., Puddington L., Lefrancois L.; RT "CD11a is essential for normal development of hematopoietic RT intermediates."; RL J. Immunol. 193:2863-2872(2014). RN [10] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=29100055; DOI=10.1016/j.molcel.2017.10.003; RA Swaim C.D., Scott A.F., Canadeo L.A., Huibregtse J.M.; RT "Extracellular ISG15 signals cytokine secretion through the LFA-1 integrin RT receptor."; RL Mol. Cell 68:581-590(2017). CC -!- FUNCTION: Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2, ICAM3 CC and ICAM4 (PubMed:2051027). Integrin ITGAL/ITGB2 is a receptor for F11R CC (By similarity). Integrin ITGAL/ITGB2 is a receptor for the secreted CC form of ubiquitin-like protein ISG15; the interaction is mediated by CC ITGAL (PubMed:29100055). Involved in a variety of immune phenomena CC including leukocyte-endothelial cell interaction, cytotoxic T-cell CC mediated killing, and antibody dependent killing by granulocytes and CC monocytes. Contributes to natural killer cell cytotoxicity. Involved in CC leukocyte adhesion and transmigration of leukocytes including T-cells CC and neutrophils (PubMed:16234355, PubMed:24158516). Required for CC generation of common lymphoid progenitor cells in bone marrow, CC indicating the role in lymphopoiesis (PubMed:25108025). Integrin CC ITGAL/ITGB2 in association with ICAM3, contributes to apoptotic CC neutrophil phagocytosis by macrophages. {ECO:0000250|UniProtKB:P20701, CC ECO:0000269|PubMed:16234355, ECO:0000269|PubMed:2051027, CC ECO:0000269|PubMed:24158516, ECO:0000269|PubMed:25108025, CC ECO:0000269|PubMed:29100055}. CC -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The ITGAL alpha CC subunit associates with the ITGB2 beta subunit. Interacts with THBD. CC {ECO:0000250|UniProtKB:P20701}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P20701}; CC Single-pass type I membrane protein {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P24063-1; Sequence=Displayed; CC Name=2; CC IsoId=P24063-2; Sequence=VSP_061239; CC -!- TISSUE SPECIFICITY: Leukocytes. {ECO:0000269|PubMed:24158516, CC ECO:0000269|PubMed:25108025}. CC -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins with CC I-domains do not undergo protease cleavage. The I-domain is necessary CC and sufficient for interaction with ICAM1 and F11R. CC {ECO:0000250|UniProtKB:P20701}. CC -!- PTM: In resting T-cells, up to 40% of surface ITGAL is constitutively CC phosphorylated. Phosphorylation causes conformational changes needed CC for ligand binding and is necessary for the activation by some CC physiological agents. {ECO:0000250|UniProtKB:P20701}. CC -!- DISRUPTION PHENOTYPE: Mice show decreased cellularity in thymus but not CC spleen, and impaired early T cell development (PubMed:25108025). Obese CC mutant mice show decreased total number of T-cells, lower levels of CC neutrophil elastase and reduced cytotoxic T-cell proliferation in CC adipose tissue, as well as improved glucose tolerance and insulin CC resistance in comparison to obese wild type mice (PubMed:24158516). CC Splenocytes from mutant mice do not respond to extracellular Isg15 as CC demonstrated by lack of Ifng secretion in contrast to wild-type cells CC which secrete Ifng in response to treatment with Isg15 CC (PubMed:29100055). {ECO:0000269|PubMed:24158516, CC ECO:0000269|PubMed:25108025, ECO:0000269|PubMed:29100055}. CC -!- SIMILARITY: Belongs to the integrin alpha chain family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAA39426.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M60778; AAA39426.1; ALT_FRAME; mRNA. DR EMBL; AK156251; BAE33641.1; -; mRNA. DR EMBL; AC133494; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC145802; AAI45803.1; -; mRNA. DR CCDS; CCDS57588.1; -. [P24063-2] DR CCDS; CCDS57589.1; -. [P24063-1] DR PIR; I56126; I56126. DR RefSeq; NP_001240801.1; NM_001253872.1. [P24063-1] DR AlphaFoldDB; P24063; -. DR SMR; P24063; -. DR ComplexPortal; CPX-3128; Integrin alphaL-beta2 complex. DR DIP; DIP-35643N; -. DR IntAct; P24063; 4. DR STRING; 10090.ENSMUSP00000101913; -. DR BindingDB; P24063; -. DR ChEMBL; CHEMBL1075188; -. DR GlyCosmos; P24063; 15 sites, No reported glycans. DR GlyGen; P24063; 16 sites, 1 O-linked glycan (1 site). DR iPTMnet; P24063; -. DR PhosphoSitePlus; P24063; -. DR SwissPalm; P24063; -. DR EPD; P24063; -. DR MaxQB; P24063; -. DR PaxDb; 10090-ENSMUSP00000101913; -. DR ProteomicsDB; 301689; -. DR ProteomicsDB; 312541; -. DR ProteomicsDB; 355028; -. DR Antibodypedia; 13698; 2405 antibodies from 47 providers. DR DNASU; 16408; -. DR Ensembl; ENSMUST00000106306.9; ENSMUSP00000101913.3; ENSMUSG00000030830.19. [P24063-1] DR Ensembl; ENSMUST00000117762.8; ENSMUSP00000113946.2; ENSMUSG00000030830.19. [P24063-2] DR GeneID; 16408; -. DR KEGG; mmu:16408; -. DR AGR; MGI:96606; -. DR CTD; 3683; -. DR MGI; MGI:96606; Itgal. DR VEuPathDB; HostDB:ENSMUSG00000030830; -. DR eggNOG; KOG3637; Eukaryota. DR GeneTree; ENSGT00940000161495; -. DR HOGENOM; CLU_004111_3_0_1; -. DR InParanoid; P24063; -. DR OMA; TVCFQLK; -. DR OrthoDB; 3816176at2759; -. DR TreeFam; TF105391; -. DR Reactome; R-MMU-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell. DR Reactome; R-MMU-202733; Cell surface interactions at the vascular wall. DR Reactome; R-MMU-216083; Integrin cell surface interactions. DR Reactome; R-MMU-6798695; Neutrophil degranulation. DR BioGRID-ORCS; 16408; 2 hits in 79 CRISPR screens. DR ChiTaRS; Itgal; mouse. DR PRO; PR:P24063; -. DR Proteomes; UP000000589; Chromosome 7. DR RNAct; P24063; Protein. DR Bgee; ENSMUSG00000030830; Expressed in granulocyte and 82 other cell types or tissues. DR ExpressionAtlas; P24063; baseline and differential. DR GO; GO:0009986; C:cell surface; ISO:MGI. DR GO; GO:0005911; C:cell-cell junction; IDA:MGI. DR GO; GO:0009897; C:external side of plasma membrane; IDA:MGI. DR GO; GO:0001772; C:immunological synapse; IDA:MGI. DR GO; GO:0034687; C:integrin alphaL-beta2 complex; ISO:MGI. DR GO; GO:0008305; C:integrin complex; IBA:GO_Central. DR GO; GO:0050839; F:cell adhesion molecule binding; ISO:MGI. DR GO; GO:0030369; F:ICAM-3 receptor activity; ISO:MGI. DR GO; GO:0005178; F:integrin binding; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0044877; F:protein-containing complex binding; ISO:MGI. DR GO; GO:0050798; P:activated T cell proliferation; IMP:MGI. DR GO; GO:0019722; P:calcium-mediated signaling; IDA:MGI. DR GO; GO:0033627; P:cell adhesion mediated by integrin; IBA:GO_Central. DR GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:MGI. DR GO; GO:0098609; P:cell-cell adhesion; IGI:BHF-UCL. DR GO; GO:0007160; P:cell-matrix adhesion; ISO:MGI. DR GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISO:MGI. DR GO; GO:0007229; P:integrin-mediated signaling pathway; IBA:GO_Central. DR GO; GO:0007159; P:leukocyte cell-cell adhesion; IDA:MGI. DR GO; GO:0035683; P:memory T cell extravasation; ISO:MGI. DR GO; GO:0006909; P:phagocytosis; IEA:UniProtKB-KW. DR GO; GO:0050850; P:positive regulation of calcium-mediated signaling; IDA:MGI. DR GO; GO:0022409; P:positive regulation of cell-cell adhesion; IMP:MGI. DR GO; GO:0042102; P:positive regulation of T cell proliferation; IMP:MGI. DR GO; GO:0043113; P:receptor clustering; ISO:MGI. DR GO; GO:0022407; P:regulation of cell-cell adhesion; IDA:MGI. DR GO; GO:0002291; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; ISO:MGI. DR Gene3D; 1.20.5.2120; -; 1. DR Gene3D; 1.20.5.930; Bicelle-embedded integrin alpha(iib) transmembrane segment; 1. DR Gene3D; 2.130.10.130; Integrin alpha, N-terminal; 2. DR Gene3D; 2.60.40.1460; Integrin domains. Chain A, domain 2; 1. DR Gene3D; 2.60.40.1510; ntegrin, alpha v. Chain A, domain 3; 1. DR Gene3D; 2.60.40.1530; ntegrin, alpha v. Chain A, domain 4; 1. DR InterPro; IPR013517; FG-GAP. DR InterPro; IPR013519; Int_alpha_beta-p. DR InterPro; IPR000413; Integrin_alpha. DR InterPro; IPR018184; Integrin_alpha_C_CS. DR InterPro; IPR013649; Integrin_alpha_Ig-like_1. DR InterPro; IPR048285; Integrin_alpha_Ig-like_2. DR InterPro; IPR028994; Integrin_alpha_N. DR InterPro; IPR032695; Integrin_dom_sf. DR InterPro; IPR002035; VWF_A. DR InterPro; IPR036465; vWFA_dom_sf. DR PANTHER; PTHR23220; INTEGRIN ALPHA; 1. DR PANTHER; PTHR23220:SF84; INTEGRIN ALPHA-L; 1. DR Pfam; PF01839; FG-GAP; 2. DR Pfam; PF08441; Integrin_A_Ig_1; 1. DR Pfam; PF20805; Integrin_A_Ig_2; 1. DR Pfam; PF00357; Integrin_alpha; 1. DR Pfam; PF00092; VWA; 1. DR PRINTS; PR01185; INTEGRINA. DR PRINTS; PR00453; VWFADOMAIN. DR SMART; SM00191; Int_alpha; 5. DR SMART; SM00327; VWA; 1. DR SUPFAM; SSF69318; Integrin alpha N-terminal domain; 1. DR SUPFAM; SSF69179; Integrin domains; 2. DR SUPFAM; SSF53300; vWA-like; 1. DR PROSITE; PS51470; FG_GAP; 7. DR PROSITE; PS00242; INTEGRIN_ALPHA; 1. DR PROSITE; PS50234; VWFA; 1. DR Genevisible; P24063; MM. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Cell adhesion; Cell membrane; KW Direct protein sequencing; Disulfide bond; Glycoprotein; Integrin; KW Magnesium; Membrane; Metal-binding; Phagocytosis; Phosphoprotein; Receptor; KW Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..23 FT /evidence="ECO:0000269|PubMed:3887182" FT CHAIN 24..1162 FT /note="Integrin alpha-L" FT /id="PRO_0000016293" FT TOPO_DOM 24..1088 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1089..1109 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1110..1162 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REPEAT 28..79 FT /note="FG-GAP 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00803" FT REPEAT 80..138 FT /note="FG-GAP 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00803" FT DOMAIN 153..325 FT /note="VWFA" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00219" FT REPEAT 336..387 FT /note="FG-GAP 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00803" FT REPEAT 390..443 FT /note="FG-GAP 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00803" FT REPEAT 444..504 FT /note="FG-GAP 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00803" FT REPEAT 505..561 FT /note="FG-GAP 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00803" FT REPEAT 565..625 FT /note="FG-GAP 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00803" FT REGION 1124..1162 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 1112..1116 FT /note="GFFKR motif" FT BINDING 466 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 468 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 470 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 474 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 528 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 530 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 532 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 536 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 588 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 592 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250|UniProtKB:P08648" FT BINDING 596 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000250|UniProtKB:P08648" FT CARBOHYD 86 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 185 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 270 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 444 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 668 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 696 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 724 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 728 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 777 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 858 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 881 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 891 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 900 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 928 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1057 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 70..77 FT /evidence="ECO:0000250" FT DISULFID 108..126 FT /evidence="ECO:0000250" FT DISULFID 147..199 FT /evidence="ECO:0000250" FT DISULFID 651..705 FT /evidence="ECO:0000250" FT DISULFID 768..774 FT /evidence="ECO:0000250" FT DISULFID 841..857 FT /evidence="ECO:0000250" FT DISULFID 994..1010 FT /evidence="ECO:0000250" FT DISULFID 1018..1049 FT /evidence="ECO:0000250" FT VAR_SEQ 743 FT /note="Missing (in isoform 2)" FT /id="VSP_061239" FT CONFLICT 973 FT /note="W -> R (in Ref. 1; AAA39426, 2; BAE33641 and 4; FT AAI45803)" FT /evidence="ECO:0000305" FT CONFLICT 979 FT /note="P -> L (in Ref. 1; AAA39426, 2; BAE33641 and 4; FT AAI45803)" FT /evidence="ECO:0000305" FT CONFLICT 1024 FT /note="R -> W (in Ref. 1; AAA39426)" FT /evidence="ECO:0000305" SQ SEQUENCE 1162 AA; 128314 MW; CA2118033958BC44 CRC64; MSFRIAGPRL LLLGLQLFAK AWSYNLDTRP TQSFLAQAGR HFGYQVLQIE DGVVVGAPGE GDNTGGLYHC RTSSEFCQPV SLHGSNHTSK YLGMTLATDA AKGSLLACDP GLSRTCDQNT YLSGLCYLFP QSLEGPMLQN RPAYQECMKG KVDLVFLFDG SQSLDRKDFE KILEFMKDVM RKLSNTSYQF AAVQFSTDCR TEFTFLDYVK QNKNPDVLLG SVQPMFLLTN TFRAINYVVA HVFKEESGAR PDATKVLVII TDGEASDKGN ISAAHDITRY IIGIGKHFVS VQKQKTLHIF ASEPVEEFVK ILDTFEKLKD LFTDLQRRIY AIEGTNRQDL TSFNMELSSS GISADLSKGH AVVGAVGAKD WAGGFLDLRE DLQGATFVGQ EPLTSDVRGG YLGYTVAWMT SRSSRPLLAA GAPRYQHVGQ VLLFQAPEAG GRWNQTQKIE GTQIGSYFGG ELCSVDLDQD GEAELLLIGA PLFFGEQRGG RVFTYQRRQS LFEMVSELQG DPGYPLGRFG AAITALTDIN GDRLTDVAVG APLEEQGAVY IFNGKPGGLS PQPSQRIQGA QVFPGIRWFG RSIHGVKDLG GDRLADVVVG AEGRVVVLSS RPVVDVVTEL SFSPEEIPVH EVECSYSARE EQKHGVKLKA CFRIKPLTPQ FQGRLLANLS YTLQLDGHRM RSRGLFPDGS HELSGNTSIT PDKSCLDFHF HFPICIQDLI SPINVSLNFS LLEEEGTPRD QKVGRAMQPI LRPSIHTVTK EIPFEKNCGE DKKCEANLTL SSPARSGPLR LMSSASLAVE WTLSNSGEDA YWVRLDLDFP RGLSFRKVEM LQPHSRMPVS CEELTEGSSL LTKTLKCNVS SPIFKAGQEV SLQVMFNTLL NSSWEDFVEL NGTVHCENEN SSLQEDNSAA THIPVLYPVN ILTKEQENST LYISFTPKGP KTQQVQHVYQ VRIQPSAYDH NMPTLEALVG VPWPHSEDPI TYTWSVQTDP LVTCHSEDLK RPSSEAEQPC LPGVQFRCPI VFRREILIQV TGTVELSKEI KASSTLSLCS SLSVSFNSSK HFHLYGSKAS EAQVLVKVDL IHEKEMLHVY VLSGIGGLVL LFLIFLALYK VGFFKRNLKE KMEADGGVPN GSPPEDTDPL AVPGEETKDM GCLEPLRESD KD //